Agenda

October 16-19, 2024 | New York City

Register

Wednesday October 16, 2024

  • 9:00 AM – 9:05 AM

    Welcome and Introduction: Leukemia Day

    • Speaker
      • Morton ColemanMD
  • +
    9:00 AM – 10:30 AM

    Session I: AML

    • Moderator
      • Gail RobozMD
    • 9:05 AM – 9:10 AM
      Session Welcome
    • 9:10 AM – 9:30 AM
      Updates in AML Diagnosis and Risk Stratification
    • 9:30 AM – 9:50 AM
      AML Clinical Management: Getting a Newly Diagnosed Patient on the Right Path
    • 9:50 AM – 10:10 AM
      How to Make Stem Cell Transplantation for AML Better, Safer, and More Available?
    • 10:10 AM – 10:30 AM
      Q&A Session
  • 10:30 AM – 11:00 AM

    Exhibit Hall

  • +
    11:00 AM – 12:45 PM

    Session II: MDS

    • Moderator
      • Michal Bar-NatanMD
    • 11:00 AM – 11:05 AM
      Session Welcome
    • 11:05 AM – 11:25 AM
      Lecture: Clinical and Genomic Characterization of Secondary Myeloid Neoplasms.
    • 11:25 AM – 11:45 AM
      Updates in the Treatment of MDS
    • 11:45 AM – 12:05 PM
      Q&A Session
    • 12:05 PM – 12:45 PM
      Case presentation: TP53 MDS
  • 12:45 PM – 2:00 PM

    Lunch Innovation Theater/Symposium (Non-Accredited) (Sponsored by AbbVie)

  • 12:45 PM – 2:00 PM

    Lunch Innovation Theater (Non-Accredited) (Sponsored by Amgen)

  • 12:45 PM – 2:00 PM

    Lunch Innovation Theater (Non-Accredited) (Sponsored by Servier)

  • 1:00 PM – 2:00 PM

    Exhibit Hall

  • +
    2:00 PM – 3:35 PM

    Session III: MPN

    • Moderator
      • Gail RobozMD
    • 2:00 PM – 2:05 PM
      Session Welcome
    • 2:05 PM – 2:15 PM
      Presentation of Best Leukemia Abstract
    • 2:15 PM – 2:35 PM
      Updates in the Management of Polycythemia Vera and Essential Thrombocytopenia
    • 2:35 PM – 2:55 PM
      Initiating and Sequencing Treatments for Myelofibrosis
    • 2:55 PM – 3:15 PM
      Updates in the Management and Monitoring of CML
    • 3:15 PM – 3:35 PM
      Q&A Session
  • 3:35 PM – 4:05 PM

    Exhibit Hall

  • +
    4:05 PM – 5:50 PM

    Session IV: Challenging Topics in Leukemia

    • Moderator
      • Gail RobozMD
    • 4:05 PM – 4:10 PM
      Session Welcome
    • 4:10 PM – 4:30 PM
      Management of CNS Leukemia
    • 4:30 PM – 4:50 PM
      Classification and Treatment of Chronic Myelomonocytic Leukemia
    • 4:50 PM – 5:10 PM
      Emerging strategies for Ph+ ALL
    • 5:10 PM – 5:30 PM
      Fertility Preservation for Myeloid Malignancy Patients
    • 5:30 PM – 5:50 PM
      Q&A Session
  • 5:50 PM – 7:15 PM

    Welcome Reception

Thursday October 17, 2024

  • 7:30 AM – 8:00 AM

    Exhibit Hall

  • +
    8:00 AM – 9:30 AM

    Session V: Basic Science: What is New and Exciting!

    • Moderator
      • Lisa RothMD
    • 8:00 AM – 8:05 AM
      Welcome and Introduction: Lymphoma Day
    • 8:05 AM – 8:10 AM
      Session Welcome
    • 8:10 AM – 8:30 AM
      How Can We Use the Immune System to Better Target Lymphoma?
    • 8:30 AM – 8:50 AM
      New Insights into Epigenetics and Lymphoma
    • 8:50 AM – 9:10 AM
      Circulating Tumor DNA and Assessment of Risk in Lymphoma
    • 9:10 AM – 9:30 AM
      Q&A Session
  • +
    8:00 AM – 9:30 AM

    Nurses and Physicians Assistant/ Associate Track: Session A

    • 8:00 AM – 8:05 AM
      Welcome and Introduction: Nurses and Physicians Assistant/ Associate Track
    • 8:05 AM – 8:45 AM
      Nutrition in Cancer Patients
    • 8:45 AM – 9:30 AM
      Fertility Preservation
  • 9:30 AM – 10:00 AM

    Exhibit Hall

  • +
    10:00 AM – 11:55 AM

    Session VI: Approaches in Indolent Lymphomas

    • Moderator
      • Erin MulveyMD
    • 10:00 AM – 10:05 AM
      Session Welcome
    • 10:05 AM – 10:25 AM
      How I Approach Initial Therapy of Follicular Lymphoma
    • 10:25 AM – 10:40 AM
      Debate- How to Prioritize Therapy for Patients with R/R FL- CAR-T
    • 10:40 AM – 10:55 AM
      Debate- How to Prioritize Therapy for Patients with R/R FL- Novel agents including BTKi, EZH2, iMIDS
    • 10:55 AM – 11:10 AM
      Debate- How to Prioritize Therapy for Patients with R/R FL- Bispecifics
    • 11:10 AM – 11:30 AM
      Updates in T cell Lymphoma
    • 11:30 AM – 11:55 AM
      Q&A Session
  • +
    10:00 AM – 10:55 AM

    Nurses and Physicians Assistant/ Associate Track Session B

    • 10:00 AM – 10:55 AM
      New Drugs in Hematology/ Oncology
  • 11:55 AM – 1:10 PM

    Lunch Innovation Theater (Non-Accredited) (Sponsored by Lilly)

  • 11:55 AM – 1:10 PM

    Lunch Innovation Theater (Non-Accredited) (Sponsored by Bristol Myers Squibb)

  • 11:55 AM – 1:10 PM

    Lunch Innovation Theater (Non-Accredited)

  • 12:10 PM – 1:10 PM

    Exhibit Hall

  • +
    1:10 PM – 3:00 PM

    Session VII: Management of Non-indolent Lymphomas

    • Moderator
      • John LeonardMD
    • 1:10 PM – 1:15 PM
      Session Welcome
    • 1:15 PM – 1:25 PM
      Presentation of Best Lymphoma Abstract:
    • 1:25 PM – 1:35 PM
      SASS-ARENA Foundation for Medical Research Award John Ultmann Award for Major Contribution to Lymphoma Research
    • 1:35 PM – 2:00 PM
      Award Lecture: What does the Future Hold for Management of Upfront and Relapsed Hodgkin Lymphoma?
    • 2:00 PM – 2:20 PM
      Management of Mantle Cell Lymphoma
    • 2:20 PM – 2:40 PM
      What’s New in Marginal Zone Lymphoma?
    • 2:40 PM – 3:00 PM
      Q&A Session
  • +
    1:40 PM – 3:30 PM

    Nurses and Physicians Assistant/ Associate Track Session C

    • 2:10 PM – 3:00 PM
      CRS/ICANS Management
  • 3:00 PM – 3:30 PM

    Exhibit Hall

  • +
    3:30 PM – 4:55 PM

    Session VIII: Aggressive Lymphomas

    • Moderator
      • Sarah RutherfordMD
    • 3:30 PM – 3:35 PM
      Session Welcome
    • 3:35 PM – 3:55 PM
      How I Approach Initial Therapy of Aggressive Lymphoma
    • 3:55 PM – 4:15 PM
      How I approach R/R therapy of Aggressive Lymphoma
    • 4:15 PM – 4:35 PM
      Where do CAR-T cells fit in the treatment of aggressive lymphoma?
    • 4:35 PM – 4:55 PM
      Q&A Session
  • +
    4:55 PM – 5:25 PM

    Session IX- Waldenstrom’s Macroglobulinemia

    • Moderator
      • John LeonardMD
    • 4:55 PM – 5:15 PM
      Lecture: The International Waldenstrom’s Macroglobulinemia Foundation Award:The Bruce Waterfall Memorial Lecture
    • 5:15 PM – 5:25 PM
      Q&A Session
  • 5:25 PM – 5:25 PM

    Adjourn

  • 5:25 PM – 6:40 PM

    Dinner Innovation Theater (Non-Accredited)

  • 6:45 PM – 7:45 PM

    LRF Grand Rounds

Friday October 18, 2024

  • 7:30 AM – 8:00 AM

    Exhibit Hall

  • +
    8:00 AM – 9:30 AM

    Session X: Biology and Pathology for Clinicians

    • Moderator
      • Mark BustorosMD
    • 8:00 AM – 8:05 AM
      Welcome and Introduction: Myeloma Day
    • 8:05 AM – 8:10 AM
      Session Welcome
    • 8:10 AM – 8:30 AM
      The T cell Compartment in MM- Therapeutic Implications of the Bench
    • 8:30 AM – 8:50 AM
      Myeloma and the Microenvironment. Comparing Marrow and Extramedullary Disease: Future Directions
    • 8:50 AM – 9:10 AM
      Precursor disorders (Smoldering Myeloma): If and When to Treat. Maintenance intervention or going for the cure
    • 9:10 AM – 9:30 AM
      Q&A Session
  • 8:00 AM – 9:30 AM

    Spanish Session in Lymphoma

    • Invited Panelist
      • Astrid PavlovskyMD
    • Moderator
      • Julio ChavezMD, MS
    • Panelist
      • Peter MartinMD
  • +
    8:00 AM – 9:30 AM

    Nurses and Physician Assistant/ Associate Track Session D

    • 8:05 AM – 8:45 AM
      Dermatologic Manifestations of Cancer
    • 8:45 AM – 9:30 AM
      Hodgkin's Lymphoma Updates
  • 9:30 AM – 10:00 AM

    Exhibit Hall

  • +
    10:00 AM – 11:55 AM

    Session XI: Upfront Treatment of Myeloma

    • Moderator
      • Jorge MongeMD
    • 10:00 AM – 10:05 AM
      Session Welcome
    • 10:05 AM – 10:25 AM
      Is MRD Ready for Prime Time?
    • 10:25 AM – 10:45 AM
      Optimal Upfront Treatment: Current and Novel Immunotherapy Approaches
    • 10:45 AM – 11:05 AM
      The High Risk Elderly Frail Patient: Should CART or Bispecifics be Incorporated?
    • 11:05 AM – 11:20 AM
      Debate: Management of A Fit Patient: Should CAR-T replace autotransplant as consolidation? Transplant
    • 11:20 AM – 11:35 AM
      Debate: Management of A Fit Patient: Should CAR-T replace autotransplant as consolidation? - CAR-T
    • 11:35 AM – 11:55 AM
      Q&A Session
  • +
    10:00 AM – 10:55 AM

    Nurses and Physician Assistant/ Associate Track Session E

    • 10:00 AM – 10:55 AM
      Bone Marrow Workshop
  • 11:55 AM – 1:10 PM

    Lunch Innovation Theater (Non-Accredited) (Sponsored by Johnson & Johnson)

  • 11:55 AM – 1:10 PM

    Lunch Innovation Theater (Non-Accredited)

  • 11:55 AM – 1:10 PM

    Lunch Innovation Theater (Non-Accredited) (Sponsored by Bristol Myers Squibb)

  • 11:55 AM – 1:10 PM

    Lunch Innovation Theater (Non-Accredited) (Sponsored by Karyopharm)

  • 12:10 PM – 1:10 PM

    Exhibit Hall

  • +
    1:10 PM – 3:30 PM

    Session XII: Evolving Options in Multiple Myeloma

    • Moderator
      • Ruben NiesvizkyMD
    • 1:10 PM – 1:15 PM
      Session Welcome
    • 1:15 PM – 1:25 PM
      Best Myeloma Abstract Presentation
    • 1:25 PM – 1:40 PM
      SASS-ARENA Foundation for Medical Research Award Joseph Michaeli Award for Contribution to Myeloma Research
    • 1:40 PM – 2:10 PM
      Award Lecture: The Immune Microenviroment in Myeloma-Therapeutic Implications
    • 2:10 PM – 2:30 PM
      How to Incorporate New Therapies in the Early Relapse Patient (1-3 prior lines)
    • 2:30 PM – 2:50 PM
      Beyond BCMA Directed CAR-T- Therapy- How New Targets are Being Exploited
    • 2:50 PM – 3:10 PM
      T Cell Engagers (Bispecifics) BCMA and Other Targets
    • 3:10 PM – 3:30 PM
      Q&A Session
  • 2:10 PM – 3:10 PM

    Lumbar Puncture Workshop

    • Speaker
      • Jeremy HeinerichPA-C
  • 2:30 PM – 3:30 PM

    Nurses and Physician Assistant/ Associate Track Session F

  • 3:30 PM – 4:00 PM

    Exhibit Hall

  • +
    4:00 PM – 6:00 PM

    Session XIII: Treatment in Relapsed/ Refractory Multiple Myeloma

    • Moderator
      • Ruben NiesvizkyMD
    • 4:00 PM – 4:05 PM
      Session Welcome
    • 4:05 PM – 4:25 PM
      The Relapsed Refractory Patient: When Immune Approaches are Ineffective
    • 4:25 PM – 4:45 PM
      The Multiple Refractory Patient: From Cell Mods to XPO1 Inhibitors
    • 4:45 PM – 5:05 PM
      Extramedullary Myeloma: Is There Any Hope? New Treatment Approaches
    • 5:05 PM – 5:25 PM
      CAR T-Cell Therapy in Multiple Myeloma: Best Practices in Patient Selection, Treatment, and Multidisciplinary Care
    • 5:15 PM – 5:35 PM
      Q&A Session
    • 5:35 PM – 6:00 PM
      Case Discussions
  • 6:00 PM – 6:00 PM

    Adjourn

  • 6:00 PM – 7:15 PM

    Dinner Innovation Theater (Non-Accredited) (Sponsored by Johnson&Johnson)

Saturday October 19, 2024

  • 7:45 AM – 8:15 AM

    Exhibit Hall

  • +
    8:15 AM – 9:45 AM

    Session XIV: New and Basic Science

    • Moderator
      • Richard FurmanMD
    • 8:15 AM – 8:20 AM
      Welcome and Introduction: CLL Day
    • 8:20 AM – 8:25 AM
      Session Welcome
    • 8:25 AM – 8:45 AM
      Is Low Count MBL a Precursor to CLL?
    • 8:45 AM – 9:05 AM
      CLL: The next Frontier
    • 9:05 AM – 9:25 AM
      Rai Lecture: Recently Born CLL Cells: Youth Is Not Wasted on the Young
    • 9:25 AM – 9:45 AM
      Q&A Session
  • 8:15 AM – 9:45 AM

    Spanish Session Myeloma

    • Moderator
      • Ruben NiesvizkyMD
    • Panelist
      • Jorge MongeMD
      • Victor Jimenez ZepedaMD
  • 9:45 AM – 10:15 AM

    Exhibit Hall

  • +
    10:15 AM – 12:20 PM

    Session XV: Treatment Approaches- Sequential and Combinatorial

    • Moderator
      • Richard FurmanMD
    • 10:15 AM – 10:20 AM
      Session Welcome
    • 10:20 AM – 10:40 AM
      What To Do with BTK Mutation Data
    • 10:40 AM – 11:00 AM
      Lecture: Sequencing BTKi vs BCL2- Frontline and Relapsed
    • 11:00 AM – 11:20 AM
      Lecture: Combination studies of BTKi and BCl2
    • 11:20 AM – 11:40 AM
      The Prince Family Lecture: How Should We Be Using MRD Data?
    • 11:40 AM – 12:00 PM
      Management of Richter Transformation
    • 12:00 PM – 12:20 PM
      Q&A Session
  • 12:20 PM – 1:35 PM

    Lunch Innovation Theater (Non-Accredited) (Sponsored by AstraZeneca)

  • 12:20 PM – 1:35 PM

    Lunch Innovation Theater/Symposium (Non-Accredited) (Sponsored by AbbVie)

  • 12:20 PM – 1:35 PM

    Lunch Innovation Theater (Non-Accredited)

  • +
    1:35 PM – 3:15 PM

    Session XVI: BTKis and CAR-T in CLL

    • Moderator
      • Richard FurmanMD
    • 1:35 PM – 1:40 PM
      Session Welcome
    • 1:40 PM – 2:00 PM
      Lecture: Noncovalent Binding BTK inhibitor - A New Novel Approach/a different binding mechanism
    • 2:00 PM – 2:20 PM
      CAR-T cells in CLL
    • 2:20 PM – 2:30 PM
      Debate- CLL: Debating Therapeutic Strategies
    • 2:30 PM – 2:40 PM
      Debate- CLL: Debating Therapeutic Strategies
    • 2:40 PM – 2:50 PM
      Debate- CLL: Debating Therapeutic Strategies
    • 2:50 PM – 3:00 PM
      Debate- CLL: Debating Therapeutic Strategies
    • 3:00 PM – 3:15 PM
      Q&A Session
  • 3:15 PM – 3:15 PM

    Adjourn